SSB
TAK icon

Sandy Spring Bank’s Takeda Pharmaceutical TAK Stock Holding History

Sandy Spring Bank’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-102
Closed -$2K – 954
2020
Q1 		$2K Buy
+102
New +$1.85K ﹤0.01% 838
2019
Q3 		– Sell
-70
Closed -$1K – 871
2019
Q2 		$1K Buy
+70
New +$1.27K ﹤0.01% 820

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Sandy Spring Bank's TAK Position: Q2 2020 in Review

Sandy Spring Bank sold out of Takeda Pharmaceutical (TAK) in Q2 2020, closing a stake of 102 shares — an estimated $2K sold.

Sandy Spring Bank first reported a position in TAK in Q2 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 308 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

  • Sandy Spring Bank reported no remaining Takeda Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Sandy Spring Bank sold 102 Takeda Pharmaceutical shares in Q2 2020, an estimated $2K.
  • Sandy Spring Bank first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 2 quarters.
  • Sandy Spring Bank's Takeda Pharmaceutical position peaked at $2K in Q1 2020.
  • 308 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on Sandy Spring Bank's 13F filing for Q2 2020, filed 12 Aug 2020.